Article
Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America - 18 Feb 1997
Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L
Abstract excerpt
The PDAPP transgenic mouse, which overexpresses human amyloid precursor protein (APP717V-->F), has been shown to develop much of the pathology associated with Alzheimer disease. In this report, levels of APP and its amyloidogenic metabolites were measured in brain regions of transgenic mice between 4 and 18 months of age. While absolute levels of APP expression likely contribute to the rate of amyloid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.